Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

4,003 public trials 391 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Tiotropium Respimat Pharmacokinetic Study in COPD

NCT01222533

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.458.32003 Boehringer Ingelheim Investigational Site Genk, Belgium
  • 205.458.32001 Boehringer Ingelheim Investigational Site Ghent, Belgium
  • 205.458.32002 Boehringer Ingelheim Investigational Site Hasselt, Belgium
  • 205.458.45001 Boehringer Ingelheim Investigational Site Copenhagen K, Denmark
View Trial Details
Completed

A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.

NCT00359788

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.325.904 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.325.925 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 205.325.909 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States
  • 205.325.912 Boehringer Ingelheim Investigational Site Long Beach, California, United States
View all 31 locations
View Trial Details
Completed

Tiotropium and Salmeterol PK Study in COPD Patients

NCT00673478

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1184.24.32001 Boehringer Ingelheim Investigational Site Genk, Belgium
  • 1184.24.32002 Boehringer Ingelheim Investigational Site Hasselt, Belgium
  • 1184.24.31001 Boehringer Ingelheim Investigational Site Heerlen, Netherlands
View Trial Details
Completed

Tiotropium / Respimat One Year Study in COPD.

NCT00387088

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.372.01012 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.372.01020 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.372.01062 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 205.372.01048 Boehringer Ingelheim Investigational Site Berkeley, California, United States
View all 334 locations
View Trial Details
Completed

A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in Japan

NCT01070784

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Research Site Nagoya, Aichi-ken, Japan
  • Research Site Toyota, Aichi-ken, Japan
  • Research Site Yanagawa, Fukuoka, Japan
  • Research Site Hiroshima, Japan
View all 17 locations
View Trial Details

Related conditions